Monte Rosa Therapeutics

Monte Rosa Therapeutics:
Clinical Stage, next-generation molecular glue-based targeted protein degradation platform developing small molecule therapeutics that selectively degrade disease-causing proteins. AI-based degron prediction targets the undruggable proteome in both oncology and other disease areas. Extensive preclinical data demonstrating potent anti-tumor activity. Lead asset MRT-2359 targeting degradation of GSPT1 and dosed first patient in 4Q22 in a Phase 1/2 study in patients with MYC-driven solid tumors, including lung cancer.
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
Europe, US - New England
Clinical Stage
Phase l or ll, Pre-Clinical Stage
Disease Space
Oncology
Listing
Public, USA
Market Cap
100MM - 500MM
Therapeutic Modalities
Platform Technology, Protein Degradation
Website:
Profiles:
Address:
WKL-136.3
Klybeckstrasse 191
Basel, Basel-Stadt
Switzerland
Klybeckstrasse 191
Basel, Basel-Stadt
Switzerland
More info:
My account:
Company Participants at Solebury Trout 1x1 Management Access Event 2022
- Markus Warmuth, CEO
Top 10 Holders of Monte Rosa Therapeutics, Inc.
Institution | OS (%) | Position | Mkt Val ($MM) | Source | Filing Date |
---|---|---|---|---|---|
NEA Management Co. | 15.89 | 7,692,298 | 55.54 | 13F | 12/31/22 |
Fidelity Management & Research Co. LLC | 10.00 | 4,838,091 | 34.93 | 13F | 12/31/22 |
Avoro Capital Advisor LLC | 8.94 | 4,325,000 | 31.23 | 13F | 12/31/22 |
T. Rowe Price Associates, Inc. (Investment Management) | 7.61 | 3,683,430 | 26.59 | 13F | 12/31/22 |
Cormorant Asset Management LP | 5.98 | 2,893,717 | 20.89 | 13F | 12/31/22 |
T. Rowe Price Investment Management, Inc. | 4.00 | 1,934,539 | 13.97 | 13F | 12/31/22 |
HBM Partners AG (Investment Management) | 3.33 | 1,609,633 | 11.62 | Funds | 12/31/22 |
Aisling Capital Management LP | 3.04 | 1,472,331 | 10.63 | 13F | 12/31/22 |
Alphabet, Inc. | 3.02 | 1,464,015 | 10.57 | 13F | 12/31/22 |
The Vanguard Group, Inc. | 2.89 | 1,399,354 | 10.10 | Funds | 2/28/23 |
Ownership data is sourced through FactSet.
Stock Market Data
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2023 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by
QuoteMedia.
Terms of Use.